Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Biofield

This article was originally published in The Gray Sheet

Executive Summary

Biofield: Begins patient enrollment for a 1,000-patient, six-center U.S. clinical trial of the Biofield Breast Examination (BBE) system, a non-invasive device designed to detect breast cancer by measuring and analyzing electrical potentials in breast tissue. Results of a recent European study of the device involving 261 patients demonstrate that the device detected 97% of malignancy cases (128/132), with a specificity of 79%. The firm plans a European launch in early 1996; Biofield officials say they are currently developing strategic alliances for sales, marketing and distribution in Europe...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005056

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel